Table 1.

List of donor human corneas used for the experiments

Cornea n.	Sex	Age	D/P	Endo count	Experiment
1	M	80	21.4	2500	Delivery method optimization
2	M	51	2.1	2700	Delivery method optimization
3	F	81	4.2	2500	Method optimization + Caspase
4	M	84	4	2500	Method optimization + Caspase
5	M	63	12	2600	Method optimization
6	M	90	4.55	2600	Method optimization
7	M	79	13	2700	Method optimization plasmid
8	F	88	2.2	2800	Method optimization plasmid
9	F	60	20	3100	Ex vivo plasmid
10	F	77	7.2	2500	Ex vivo siGlo
11	F	82	17.5	2800	Ex vivo siGlo
12	F	76	8	2300	Ex vivo plasmid
13	F	85			Ex vivo siGlo + plasmid
14	M	79			Ex vivo siGlo + plasmid
15	F	80	10	2217	Ex vivo p16 Ab optimization
16	M	83	5.2	1501	Ex vivo p16 Ab optimization
17	M	78	10	2057	Ex vivo p16 Ab optimization
18	F	72	21	1639	Ex vivo siRNA delivery
19	F	79	23	2283	Ex vivo siRNA delivery
20		81	15.3	2057	Ex vivo siGlo delivery + siRNA KD
21		81	15.3	2222	Ex vivo siGlo delivery + siRNA KD

Cornea n.	Sex	Age	D/P	Endo count	Experiment
22		80	21.5	2192	Ex vivo siGlo delivery + siRNA KD
23		80	21.5	2120	Ex vivo siGlo delivery + siRNA KD
24	M	67	6	1900	In vitro siGlo delivery + siRNA KD
25	F	77	23	1700	In vitro siGlo delivery + siRNA KD
26	M	45	10		In vitro siGlo delivery + siRNA KD
27	F	78	20		In vitro siGlo delivery + siRNA KD
28	M	66	21	1800	In vitro siGlo delivery + siRNA KD
29	F	48	20		Ex vivo interface ZO‐1
30		26	21	3268	In vitro Caspase and interface
31	M	73	9	1800	Ex vivo siRNA delivery
32	F	75	23		Ex vivo siRNA delivery
33		74	5	1900	Ex vivo siRNA delivery